Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8797 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8779 |
High Similarity |
NPD943 |
Approved |
0.8779 |
High Similarity |
NPD1240 |
Approved |
0.8647 |
High Similarity |
NPD1607 |
Approved |
0.8519 |
High Similarity |
NPD1510 |
Phase 2 |
0.85 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8429 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8244 |
Intermediate Similarity |
NPD1164 |
Approved |
0.8207 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8125 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.8106 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8102 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8077 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8058 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8058 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8058 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8058 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8058 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8058 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8041 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7986 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7917 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7887 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7852 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD74 |
Approved |
0.7823 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7793 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7769 |
Intermediate Similarity |
NPD846 |
Approved |
0.7769 |
Intermediate Similarity |
NPD940 |
Approved |
0.7762 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7752 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7746 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7742 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7742 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7742 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7733 |
Intermediate Similarity |
NPD1934 |
Approved |
0.773 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7708 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7692 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7615 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7534 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7532 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD2798 |
Approved |
0.75 |
Intermediate Similarity |
NPD2532 |
Approved |
0.75 |
Intermediate Similarity |
NPD2534 |
Approved |
0.75 |
Intermediate Similarity |
NPD2533 |
Approved |
0.75 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7481 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7481 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD9261 |
Approved |
0.74 |
Intermediate Similarity |
NPD920 |
Approved |
0.7365 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7361 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7353 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3764 |
Approved |
0.729 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7273 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7267 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7256 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7177 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7132 |
Intermediate Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7087 |
Intermediate Similarity |
NPD1237 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7071 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7063 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD919 |
Approved |
0.703 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7014 |
Intermediate Similarity |
NPD520 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7008 |
Intermediate Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.7008 |
Intermediate Similarity |
NPD1929 |
Approved |
0.7008 |
Intermediate Similarity |
NPD1930 |
Approved |
0.7007 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7 |
Intermediate Similarity |
NPD3400 |
Discontinued |
0.6988 |
Remote Similarity |
NPD7251 |
Discontinued |
0.697 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6962 |
Remote Similarity |
NPD2296 |
Approved |
0.6962 |
Remote Similarity |
NPD5402 |
Approved |
0.6962 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD1247 |
Approved |
0.6946 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.694 |
Remote Similarity |
NPD5951 |
Approved |
0.6935 |
Remote Similarity |
NPD1809 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6914 |
Remote Similarity |
NPD5711 |
Approved |
0.6914 |
Remote Similarity |
NPD5710 |
Approved |
0.6913 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6911 |
Remote Similarity |
NPD845 |
Approved |
0.6892 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6861 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6857 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6831 |
Remote Similarity |
NPD3266 |
Approved |
0.6831 |
Remote Similarity |
NPD3267 |
Approved |
0.6828 |
Remote Similarity |
NPD411 |
Approved |
0.6818 |
Remote Similarity |
NPD3022 |
Approved |
0.6818 |
Remote Similarity |
NPD3021 |
Approved |
0.6809 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD447 |
Suspended |
0.6803 |
Remote Similarity |
NPD1933 |
Approved |
0.68 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.68 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6783 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD1196 |
Approved |
0.6774 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6772 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6761 |
Remote Similarity |
NPD3225 |
Approved |
0.6759 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6753 |
Remote Similarity |
NPD1543 |
Discontinued |
0.675 |
Remote Similarity |
NPD4288 |
Approved |
0.6742 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6741 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6739 |
Remote Similarity |
NPD1759 |
Phase 1 |
0.6738 |
Remote Similarity |
NPD1608 |
Approved |
0.6735 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6732 |
Remote Similarity |
NPD2354 |
Approved |
0.6732 |
Remote Similarity |
NPD6190 |
Approved |
0.6726 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6724 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.6714 |
Remote Similarity |
NPD3026 |
Approved |
0.6714 |
Remote Similarity |
NPD3023 |
Approved |
0.6712 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6711
|
Remote Similarity |
NPD1195 |
Approved |